Join us for expert-led panel sessions featuring speakers fromMorgan Health, GE HealthCare, Alfie Health, Visana and more. "The conference provides a boutique platform for investors and entrepreneurs to gather, acquire insights, and exchange ideas about progress in the healthtech ecosystem."~ Dennis Depenbush, President, MHIN and New Ventures, BCBS Kansas.
Immersive scenarios in VR allow nursing education programs to enhance and scale the hands-on experiences they provide learners for developing and practicing critical skills.
Gilead Sciences' partnership with Merus could yield novel antibody drugs capable of binding to three targets simultaneously. The alliance follows a collaboration that Gilead started last year with Tentarix Biotherapeutics, a startup also developing antibodies that bind to multiple targets.
Women's health advocates overwhelmingly came out in support of the White House's $100 million investment into women's health research. However, some noted shortcomings in where the funding is going.
This case, about the claim that Merck failed to warn patients about the risk of typical femoral fracture, reaches past this suit to potentially change pharmaceutical companies' relationship with the FDA.
For this episode of the MedCity Moves Podcast, Katie Adams chats with Adam Petrich, who recently became QuantHealth's first chief medical officer. Learn more about Petrich's career journey in the pharmaceutical world and why he made the move to QuantHealth.
No comments